<p style="text-align: center;" /><p class="MsoNormal"><b style="color: rgb(0, 0, 255);"><span lang="EN-US" style="font-family: Arial; font-size: 18px;">TYPES OF
OSTEOPETROSIS</span></b><span lang="EN-US" style="font-family: Arial;"><br />
<br />
The disease occurs in a variety of forms, listed here in approximate order of
severity beginning with the mildest:<br />
<br />
<p /></span></p>
<p class="MsoNormal"><b><i><span lang="EN-US" style="font-family: Arial;"><span style="font-size: 18px; color: rgb(0, 0, 255);">Transient Infantile
Osteopetrosis</span><br />
<br />
<p /></span></i></b></p>
<p class="MsoNormal"><span lang="EN-US" style="font-family: Arial;">This is the least
reported form of the disease and resolves without intervention. It may
represent a mild form of the disease showing early in the life of a carrier,
although this has not been proven. The importance of knowing of this disease
subtype is that it highlights the need to perform a check X-ray in any child
about to undergo bone marrow transplantation just before chemotherapy
commences. This will reduce the risk (albeit very small) of transplanting a
child with self-resolving osteopetrosis.<p /></span></p>
<p class="MsoNormal"><span lang="EN-US" style="font-family: Arial;"><p> </p></span></p>
<p class="MsoNormal"><span lang="EN-US" style="font-family: Arial;"><br />
<b><i><span style="color: rgb(0, 0, 255); font-size: 18px;">Adult,
"benign", Autosomal Dominant Osteopetrosis</span><br />
</i></b><br />
This was the first form of the disease to be described, by a German radiologist
called Albers-Schönberg, and occurs in two forms:<br />
<br />
* Type I which is typified by thickening (sclerosis) of the dome of the skull
(skull vault)<br />
<br />
* Type II (classical Albers-Schönberg disease) where the spine has a so-called
"rugger jersey" striped appearance and the pelvic bones contain
endobones.<br />
<br />
This is the commonest form of the disease and is usually diagnosed in
adolescence or early adulthood. Different estimates suggest that between 1 in
every 20,000-500,000 people are affected. Inheritance is autosomal dominant
although the disease may vary in severity between generations of the family.
The most common symptoms are an increased risk of fracture, back / bone pain,
headache and osteomyelitis (infection of the bone). Problems due to nerve
compression (deafness, visual loss and facial nerve paralysis) occur much more
rarely than in the severe infant forms.<br />
<br />
The gene responsible for most cases of type II disease has been pinpointed to the
ClCN7 chloride channel gene.<p /></span></p>
<p class="MsoNormal"><span lang="EN-US" style="font-family: Arial;"><br />
<b><i><span style="font-size: 18px; color: rgb(0, 0, 255);">Carbonic
Anhydrase type II (CAII) Deficiency</span><br />
</i></b><br />
This disease is caused by a deficiency of an enzyme, CAII, which has activity
in bones, kidneys and the brain, and all of these organs are therefore
affected. It is rare and principally affects children of </span><span lang="EN-US" style="font-family: Arial;">Mediterranean</span><span lang="EN-US" style="font-family: Arial;"> and Arab race. The gene responsible for
producing CAII is found on chromosome 8 (at 8q22). As well as causing increased
bone density and a tendency to fracture easily there are characteristic changes
in body chemistry. The blood is slightly acidic and has a high chloride
concentration ("hyperchloraemic acidosis"). The blood acidity is
caused by excessive leakage of bicarbonate from the kidney tubules (termed
renal tubular acidosis). CAII must also have an important role in the brain and
affected children therefore develop progressive cerebral calcification and
mental retardation. Growth failure and dental malocclusion are other problems.<br />
<br />
This disease usually causes symptoms in the first few years of life although
X-rays are normal at birth. X-ray appearances often improve again in later
life. Approximately three fifths of children develop nerve compression where
nerves pass through the skull: this most commonly causes blindness, but can
also result in hearing loss and facial palsy. Unlike malignant infantile
osteopetrosis described below blood problems tend to be minor or absent.<br />
<br />
Treatment with oral bicarbonate supplements does not seem to change the course
of the disease. Bone marrow transplantation normalises bone density by
providing healthy osteoclasts, but does not seem to prevent cerebral
calcification and mental decline.<br />
<br />
This disease should be excluded in every child with osteopetrosis, at the very
least by scrutiny of blood bicarbonate and chloride and urine pH, but
preferably by measuring CAII activity. This is particularly important in
children of </span><span lang="EN-US" style="font-family: Arial;">Mediterranean</span><span lang="EN-US" style="font-family: Arial;"> or Arab race and in children lacking
blood derangement.<br />
<br />
<p /></span></p>
<p class="MsoNormal"><b><i><span lang="EN-US" style="font-family: Arial;"><span style="color: rgb(0, 0, 255); font-size: 18px;">Malignant Infantile Osteopetrosis</span><br />
</span></i></b><span lang="EN-US" style="font-family: Arial;"><br />
This is the commonest of the severe forms of infantile osteopetrosis and is
caused by faults in at least four different genes. Most children develop severe
nerve damage early in life and two thirds of affected children die by the age
of 6 years without treatment. Currently the only curative treatment is bone
marrow transplantation. This can completely prevent further progression of the
disease in most children, although in a small percentage of cases the bones do
not respond.<br />
<br />
The commonest symptoms in order of frequency are:<br />
<br />
<p /></span></p>
<ul type="disc" style="margin-top: 0cm;"><li class="MsoNormal"><span lang="EN-US" style="font-family: Arial;">Snuffles<br />
<br />
Nasal congestion and discharge start very early in life and are generally
constant. This is caused by overgrowth of the upper nasal bones and not,
as some think, by persistent viral infections.<br />
<br />
<p /></span></li><li class="MsoNormal"><span lang="EN-US" style="font-family: Arial;">Impaired vision<br />
<br />
This is the commonest symptom leading to medical diagnosis and is typically
apparent by the </span><span lang="EN-US" style="font-family: Arial;">second to fourth</span><span lang="EN-US" style="font-family: Arial;"> month of life. Approximately 75% of
children with malignant infantile osteopetrosis will develop visual
impairment, almost always within the first year of life. In many children
optic nerve damage becomes apparent at around 6-8 weeks when they would
usually begin to fix and follow faces, lights and large objects. Due to
lack of proper fixation the eyes begin to scan rapidly from side to side.
These wobbly movements are called nystagmus.<br />
<br />
The optic nerve carries impulses from the retina at the back of the eye to
the brain and passes through a bony optic canal in the skull on its way
from the eye socket to the brain. If formation of new bone by osteoblasts
in this area is not opposed by osteoclasts the canal progressively narrows,
putting pressure on the blood vessels which surround the nerve and feed
it. This can be seen on computerised tomography (CT) scans as shown below.
In the cross-sectional scan the eyeballs can faintly be seen at the top.
The optic nerve travels back from the middle of the eye ball passing
through a passage in the bone - the optic canal. This is narrowed on the
right hand side of this scan.<p /></span></li></ul>
<p class="MsoNormal"><span lang="EN-US" style="font-family: Arial;"><p> </p></span></p><br /><p />